Forearm Single X-Ray Absorptiometry in the Identification of Postmenopausal Women With Osteoporosis at the Hip and Spine: A Correlation Study


    loading  Checking for direct PDF access through Ovid

Abstract

The International Society for Clinical Densitometry (ISCD) has stated that forearm bone mineral density (BMD) testing combined with a thorough clinical evaluation may be an option for the diagnosis of osteoporosis when central bone density (CBD) testing is not available. This study assessed the performance of two different forearm sites in identifying subjects with spinal and femoral osteoporosis, and defined the 90% sensitivity point for the DTX-100 bone densitometer in the detection of central osteoporosis. Four hundred and two postmenopausal Bulgarian women between the ages of 50 and 81 yr (mean age 60.24 ± 10.48 yr) participated in this study. Forearm BMD (distal and ultradistal forearm) was measured with a DTX-100 device (Osteometer Meditech, USA) and central BMD (lumbar spine and proximal femur) with a Hologic QDR 4500 A device. Linear T-score correlations among sites, sensitivity and specificity of the forearm site were analyzed. T-score correlations between the forearm and the central sites ranged from 0.32 to 0.69 (p ≤ 0.05 for all correlations in age group 50–59). The forearm site sensitivity increased slightly with advancing age, but specificity decreased. When the distal forearm BMD cut point (0.340 g/cm2) was set to achieve 90% sensitivity to identify total hip osteoporosis, specificity was 40%; when the distal forearm BMD cut point (0.410 g/cm2) was set to achieve 90% sensitivity to identify spinal osteoporosis, specificity was 55.4%; when ultradistal forearm BMD cut points (0.280 and 0.320 g/cm2) were set to achieve 90% sensitivity to identify total hip and spinal osteoporosis, specificity was 40.8 and 59.2%, respectively. Forearm bone density measures may be useful to selectively screen for patients with central osteoporosis.

    loading  Loading Related Articles